Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of EUR 132.00 billion. The enterprise value is 175.60 billion.

Market Cap	132.00B
Enterprise Value	175.60B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Jan 24, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 17.02.

PE Ratio	17.02
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.73, with an EV/FCF ratio of 18.49.

EV / Earnings	22.64
EV / Sales	2.99
EV / EBITDA	7.73
EV / EBIT	11.58
EV / FCF	18.49

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.76.

Current Ratio	1.17
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	2.75
Debt / FCF	6.85
Interest Coverage	5.28

Financial Efficiency

Return on equity (ROE) is 9.06% and return on invested capital (ROIC) is 6.37%.

Return on Equity (ROE)	9.06%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	6.37%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	758,732
Profits Per Employee	95,767
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.89% in the last 52 weeks. The beta is 0.54, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-10.89%
50-Day Moving Average	24.64
200-Day Moving Average	25.64
Relative Strength Index (RSI)	35.24
Average Volume (20 Days)	72,553

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.21

Income Statement

In the last 12 months, Pfizer had revenue of EUR 61.46 billion and earned 7.76 billion in profits. Earnings per share was 1.36.

Revenue	61.46B
Gross Profit	45.60B
Operating Income	15.77B
Pretax Income	7.75B
Net Income	7.76B
EBITDA	22.53B
EBIT	15.77B
Earnings Per Share (EPS)	1.36

Full Income Statement

Balance Sheet

The company has 19.78 billion in cash and 65.12 billion in debt, giving a net cash position of -45.34 billion.

Cash & Cash Equivalents	19.78B
Total Debt	65.12B
Net Cash	-45.34B
Net Cash Per Share	n/a
Equity (Book Value)	85.48B
Book Value Per Share	15.03
Working Capital	7.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.31 billion and capital expenditures -2.81 billion, giving a free cash flow of 9.50 billion.

Operating Cash Flow	12.31B
Capital Expenditures	-2.81B
Free Cash Flow	9.50B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of 25.66% and 12.62%.

Gross Margin	74.19%
Operating Margin	25.66%
Pretax Margin	12.61%
Profit Margin	12.62%
EBITDA Margin	36.65%
EBIT Margin	25.66%
FCF Margin	15.46%

Dividends & Yields

This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 6.82%.

Dividend Per Share	1.58
Dividend Yield	6.82%
Dividend Growth (YoY)	4.49%
Years of Dividend Growth	1
Payout Ratio	118.44%
Buyback Yield	0.16%
Shareholder Yield	6.98%
Earnings Yield	5.88%
FCF Yield	7.20%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	n/a